FFA
GILD icon

Frazier Financial Advisors’s Gilead Sciences GILD Stock Holding History

Frazier Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57K Buy
52
+48
+1,200% +$6.32K ﹤0.01% 463
2026
Q1 		$562 Sell
4
-28
-88% -$3.92K ﹤0.01% 693
2025
Q4 		$3.93K Buy
32
+31
+3,100% +$3.77K ﹤0.01% 496
2025
Q3 		$137 Sell
1
-11
-92% -$1.25K ﹤0.01% 622
2025
Q2 		$1.34K Hold
12
– – ﹤0.01% 531
2025
Q1 		$1.34K Sell
12
-11
-48% -$1.14K ﹤0.01% 511
2024
Q4 		$2.1K Hold
23
– – ﹤0.01% 507
2024
Q3 		$1.9K Sell
23
-35
-60% -$2.67K ﹤0.01% 714
2024
Q2 		$4.01K Buy
58
+32
+123% +$2.14K ﹤0.01% 670
2024
Q1 		$1.92K Sell
26
-82
-76% -$6.31K ﹤0.01% 748
2023
Q4 		$8.74K Buy
+108
New +$8.4K 0.01% 378

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Frazier Financial Advisors's GILD Position: Q2 2026 in Review

Frazier Financial Advisors increased its Gilead Sciences (GILD) stake by 1,200% in Q2 2026, buying an estimated $6.32K and bringing the position to 52 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Frazier Financial Advisors first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.74K in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Frazier Financial Advisors held 52 shares of Gilead Sciences worth $6.57K as of Q2 2026.
  • Frazier Financial Advisors bought 48 Gilead Sciences shares in Q2 2026, an estimated $6.32K.
  • Gilead Sciences made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #463 holding.
  • Frazier Financial Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Gilead Sciences position peaked at $8.74K in Q4 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.